Session 5 - Roundtable From lab to market: Overcoming challenges to commercialization of bioprocesses

Tuesday, November 5, 2013: 2:30 PM-4:00 PM
Islands Ballroom F-J (Marriott Marco Island)
Convener:
Stephen Van Dien - Genomatica, Inc., San Diego, CA



2:45 PM
S30
The production of propionic acid through sugar fermentation: an industrial perspective on the progress, technical challenges and future outlook
Chris Stowers1, Brandon Rodriguez2 and Brad Cox1, (1)Bioengineering and Bioprocess R&D, Dow AgroSciences, Indianapolis, IN, (2)Hydrocarbons and Energy R&D, Dow Chemical, Freeport, TX
3:00 PM
S31
Bio-based Technology Commercialization: The role of lab to pilot scale-up
Susanne Kleff and James Wynn, MBI International, Lansing, MI
3:15 PM
S32
Understanding the biochemistry of biosynthesis can lead to titer improvements and new product discovery
Leonard Katz, QB3 Institute, University of California, Berkeley, Emeryville, CA
3:30 PM
S33
3:45 PM
tba
Gary Folkert, Biotechnology Development Center, Cargill, Inc., Excelsior, MN
See more of: Invited Oral Papers